Saphetor SA and Swift Biosciences Announce Partnership to Standardize and Accelerate Data Interpretation for Targeted NGS Panels

Lausanne, June 12th, 2019 Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with Swift Biosciences Inc., a Michigan company based in Ann Arbor, USA, offering a set of differentiated next-generation sequencing (NGS) products and technologies for genomics, translational, and clinical research applications.... Read more

Swift Biosciences Launches Swift Hybridization Capture Kits for Targeted Sequencing of Human Exome, Pan-cancer and Inherited Diseases

(ANN ARBOR, Mich. – March 26, 2019) Swift Biosciences today announced the launch of its Swift Hybridization Capture Kits, enabling enrichment and sequencing of the human exome or subsets of disease-related genes involved in cancer and inherited diseases. Swift Hybridization Capture Kits save sequencing costs by targeting only genes of interest using a 4-hour capture,... Read more

Swift Biosciences Launches Swift Amplicon 16S+ITS Panel, Answering Long-Awaited Need for Comprehensive, Rapid Coverage of Metagenomic Sequences by NGS

(ANN ARBOR, Mich. – January 16, 2019) Swift Biosciences today announced the launch of its Swift Amplicon 16S+ITS Panel, facilitating routine NGS analysis of complex microbial samples (e.g. bacteria, archaea, fungi) using a single, multiplexed primer pool targeting the 16S rRNA gene (all variable regions, V1-V9) and ITS1 and ITS2 for fungi. With a comprehensive... Read more

Swift Biosciences Announces ISO 13485:2016 Certification

Ann Arbor, Michigan (January 7, 2019) – Swift Biosciences, Inc. a manufacturer of precision next-generation sequencing (NGS) solutions, announces it has received International Organization Standardization (ISO) 13485:2016 certification for design, development, production, and distribution of molecular biology and related reagents in both standard and custom formats has been assessed and approved by National Quality assurance,... Read more

Swift Biosciences Launches Normalase™, Radically Streamlining and Improving NGS Library Normalization

(ANN ARBOR, Mich. – November 28, 2018) Swift Biosciences today announced the availability of its eagerly anticipated Normalase™ Kit, a revolutionary enzymatic library normalization product that streamlines the cumbersome steps following next-generation sequencing (NGS) library preparation. Compared to conventional normalization, Swift Normalase saves cost on sequencing by reducing read depth variation within a pool down to... Read more

Swift Biosciences Launches Swift Amplicon HS Panels, Enabling Confident Targeted Detection of Low Frequency Variants from Liquid Biopsy Sequencing

(ANN ARBOR, Mich. – Aug. 28, 2018 ) Swift Biosciences today announced early access availability of its Swift Amplicon HS Panels, a new, high-sensitivity targeted amplicon library preparation kit for next-generation sequencing (NGS) of liquid biopsy samples, including cell-free DNA (cfDNA). This addition to Swift’s targeted NGS portfolio facilitates the detection and validation of mutations occurring at... Read more

Swift Biosciences Launches Swift 2S Turbo Library Kit, Accelerating Whole Genome, Exome and Large Gene Studies with One Universal Approach

(ANN ARBOR, Mich. – July 18, 2018) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced early access to its Swift 2S Turbo Library Kit. These new kits offer a fast, robust enzymatic fragmentation prep and flexible adapter options to produce high-quality libraries for production-scale sequencing. With an automation... Read more

Swift Biosciences and Genomenon Announce Partnership to Accelerate Biomarker Selection for Targeted NGS Panels

Two Ann Arbor biotech companies provide translational researchers a faster, more comprehensive way to design Accel-Amplicon panels for variant discovery and screening studies ANN ARBOR, Michigan – May 23, 2018) – Swift Biosciences—the NGS Library Prep company—and Genomenon—the leading genomic literature search engine company— announced today a new partnership to revolutionize the design of targeted gene... Read more

Swift Biosciences Builds on Momentum, Accelerates Growth with Addition of Nathan Wood as New CEO

Results-driven, customer-focused leader to drive continued expansion in personalized medicine, disease research markets (ANN ARBOR, Mich. – May 23, 2018) Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today named industry veteran Nathan Wood as its new CEO. The hire is the latest in a recent series of strategic moves by... Read more

Swift Biosciences Launches Accel-Amplicon™ Plus Cancer Panels for Precision Medicine Initiatives

New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening (ANN ARBOR, Mich. – April 18, 2018) Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a suite of nine tumor-specific and focused gene panels to facilitate targeted cancer sequencing. The Accel-Amplicon... Read more